TARGET CELL DEATH BY CYTOTOXIC LYMPHOCYTES
细胞毒性淋巴细胞导致靶细胞死亡
基本信息
- 批准号:6289235
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The granule exocytosis model of lymphocyte-mediated cytotoxicity postulates an antigen-triggered rapid secretion of the preformed potent lytic agent perforin (as well as other mediators) into the synapse-like space between the cytotoxic lymphocyte and its bound target. However, the question of why the effector cell does not itself die of perforin damage has often been raised without a clear answer. We have recently carried out a series of experiments designed to test a new model for self-protection which proposes that cysteine proteases on the effector cell membrane inactivate inserted perforin before it can aggregate and form pores. We have tested this model by asking if 1) active cysteine proteases are detectable on the surface of cytotoxic lymphocytes, and 2) cysteine protease inhibitors block self-protection and result in degranulation-induced death in cytotoxic lymphocytes. We have detected active cysteine proteases on the surface of cytotoxic T lymphocytes by labeling them with a biotinylated cathepsin affinity reagent and with the protein inhibitor cystatin B Subsequent analysis by flow cytometry shows that cysteine proteases are detectable on cytotoxic T lymphocytes by this approach, and that they increase upon TcR triggering. Evidence that they may be involved in self-protection comes from studies in which these cathepsin inhibitors induce apoptotic death in CTL within 4 hours when incubated on wells coated with antibodies cross-linking the T cell receptor but not control Mabs. These cathepsin inhibitors show negligible ability to kill resting CTL, and control reagents with the same reactive group but an inappropriate peptide fail to induce death after TcR engagement. This death of CTL is calcium-dependent, blocked by the granule toxin concanamycin B, and is not seen in perforin- deficient CTL. Human NK cells show a similar death in the presence of cathepsin inhibitors when incubated on wells coated with degranulating anti-CD16 Mab, but not control Mab. These results support the hypothesis that cytotoxic lymphocytes use proteolysis by surface cathepsins to protect themselves against membrane damage by secreted perforin.The nature of the cathepsin responsible for the above results is under investigation, and some evidence suggests both the lysosomal cathepsins B and L are expressed on the T lymphocyte surface. Cathepsin W is a novel cathepsin originally described as an espressed sequence tag and subsequently found in mRNA expression studies to be expressed exclusively in cytotoxic lymphocytes (both T and NK cells). Since it is an obvious candidate for the above activity, we have expressed human pre-procathepsin W in E. coli and made a series of monoclonal antibodies against it. In Western blots, some of these react with a single 30kd band in mouse CTL, a size expected for active cathepsin W. Experiments are currently under way to see if cathepsin W is localized in granules, on the cell surface, or elsewhere, and if it is involved in self-protection. - Apoptosis, caspase, CTL, Cytotoxicity, Death, granzyme, lymphocyte, NK, protease,
淋巴细胞介导的细胞毒性的颗粒胞吐作用模型假定抗原触发将预先形成的强效裂解剂穿孔素(以及其他介质)快速分泌到细胞毒性淋巴细胞与其结合靶标之间的突触样空间中。然而,为什么效应细胞本身不会因穿孔素损伤而死亡的问题经常被提出,但没有明确的答案。我们最近进行了一系列实验,旨在测试一种新的自我保护模型,该模型提出效应细胞膜上的半胱氨酸蛋白酶在插入的穿孔素聚集并形成孔之前使其失活。我们通过询问是否 1) 在细胞毒性淋巴细胞表面可检测到活性半胱氨酸蛋白酶,以及 2) 半胱氨酸蛋白酶抑制剂阻止自我保护并导致细胞毒性淋巴细胞脱颗粒诱导死亡来测试该模型。我们通过用生物素化组织蛋白酶亲和试剂和蛋白质抑制剂胱抑素 B 标记细胞毒性 T 淋巴细胞表面,检测到活性半胱氨酸蛋白酶。随后的流式细胞术分析表明,通过这种方法可以在细胞毒性 T 淋巴细胞上检测到半胱氨酸蛋白酶,并且它们在 TcR 触发时增加。它们可能参与自我保护的证据来自于研究,在这些研究中,当这些组织蛋白酶抑制剂在涂有与 T 细胞受体交联的抗体但不与对照 Mab 交联的孔中孵育时,4 小时内会诱导 CTL 细胞凋亡。这些组织蛋白酶抑制剂杀死静息 CTL 的能力可以忽略不计,而具有相同反应基团但不适当肽的对照试剂在 TcR 接合后未能诱导死亡。 CTL 的这种死亡是钙依赖性的,可被颗粒毒素刀那霉素 B 阻断,并且在穿孔缺陷的 CTL 中未见。当在涂有脱颗粒抗 CD16 Mab 的孔中孵育时,人 NK 细胞在存在组织蛋白酶抑制剂的情况下表现出类似的死亡,但对照 Mab 则不然。这些结果支持细胞毒性淋巴细胞利用表面组织蛋白酶的蛋白水解作用来保护自身免受分泌性穿孔素造成的膜损伤的假设。导致上述结果的组织蛋白酶的性质正在研究中,一些证据表明溶酶体组织蛋白酶 B 和 L 都在 T 淋巴细胞表面表达。组织蛋白酶 W 是一种新型组织蛋白酶,最初被描述为表达序列标签,随后在 mRNA 表达研究中发现仅在细胞毒性淋巴细胞(T 细胞和 NK 细胞)中表达。由于它是上述活性的明显候选者,我们在大肠杆菌中表达了人前组织蛋白酶 W,并制备了一系列针对它的单克隆抗体。在蛋白质印迹中,其中一些与小鼠 CTL 中的单个 30kd 条带发生反应,这是活性组织蛋白酶 W 预期的大小。目前正在进行实验,看看组织蛋白酶 W 是否定位在颗粒中、细胞表面或其他地方,以及它是否参与自我保护。 - 细胞凋亡、半胱天冬酶、CTL、细胞毒性、死亡、颗粒酶、淋巴细胞、NK、蛋白酶、
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pierre A Henkart其他文献
Pierre A Henkart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pierre A Henkart', 18)}}的其他基金
Non-cytotoxic functions of lymphocyte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6948361 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
7292106 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
7070841 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6758411 - 财政年份:
- 资助金额:
-- - 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
- 批准号:
6557495 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual